Opko Health OPK
NASDAQ OPK
$1.71 +0.02 (+1.18%)
As of: Sep 22, 2026 · 10:48 AM EDT

Opko Health (OPK) EBITDA Margin (2010 - 2026)

Opko Health's (OPK) quarterly EBITDA Margin came in at 4.26% in Q2 2026, up 3399.0% on a YoY basis from 0.12% in Q2 2025, and up 89.62% quarter-over-quarter from 41.08% in Q1 2026.

Analysis

Opko Health (OPK) EBITDA Margin (2010 - 2026) Analysis & Trends

Opko Health (OPK) has reported EBITDA Margin for 17 consecutive years, with 4.26% the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, EBITDA Margin rose 3399.0% year-over-year to 4.26%; the trailing twelve-month figure through Jun 2026 stood at 8.21% (up 2897.0% YoY), and the FY2025 full-year result was 19.35%, up 198.0% from the prior year.
  • EBITDA Margin advanced to 4.26% in Q2 2026 per OPK's latest filing, from 41.08% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 31.68% in Q3 2025 and bottomed at 48.86% in Q3 2022.
  • Historically, EBITDA Margin has averaged 24.23% across 5 years, with a median of 29.82% in 2022.
  • The sharpest annual moves came in 2022 and 2025: EBITDA Margin plunged 5866 bps in 2022, then surged 5414 bps in 2025.
  • Over 5 years, EBITDA Margin stood at 29.82% in 2022, then dropped by 27 bps to 37.96% in 2023, then jumped by 41 bps to 22.46% in 2024, then dropped by 15 bps to 25.81% in 2025, then surged by 83 bps to 4.26% in 2026.
  • According to Business Quant data, EBITDA Margin over the past three periods registered 4.26%, 41.08%, and 25.81% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 28.21%
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 37.86%
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -3.52%
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 32.97%
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 28.37%
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 2.77%
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 9.03%
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 19.06%
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn -4.26%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.26%
Mar 31, 2026 -41.08%
Dec 31, 2025 -25.81%
Sep 30, 2025 31.68%
Jun 30, 2025 -38.25%
Mar 31, 2025 -44.79%
Sep 30, 2024 -22.46%
Jun 30, 2024 -37.41%
Mar 31, 2024 -41.15%
Dec 31, 2023 -37.96%
Sep 30, 2023 -36.06%
Jun 30, 2023 2.65%
Mar 31, 2023 -12.88%
Dec 31, 2022 -29.82%
Sep 30, 2022 -48.86%
Jun 30, 2022 -3.47%
Mar 31, 2022 -22.00%
Dec 31, 2021 -15.72%
Sep 30, 2021 9.80%
Jun 30, 2021 1.26%
API Access

Opko Health EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OPK&period=max&api_key=YOUR_API_KEY